InoueN,FukudaS,InadaT,etal.Effectofibudilastonthereciprocalinhibitoryvisual-vestibularinteractioncloselyrelatedtodizzinessaftercerebralischemia.JStrokeCerebrovascDis.2014Jan;23(1):51-5.PMID:23085301.
KiebalaM,MaggirwarSB.Ibudilast,apharmacologicphosphodiesteraseinhibitor,preventshumanimmunodeficiencyvirus-1Tat-mediatedactivationofmicroglialcells.PLoSOne.2011Apr8;6(4):e18633.PMID:21494611.
ChoY,CrichlowGV,VermeireJJ,etal.Allostericinhibitionofmacrophagemigrationinhibitoryfactorrevealedbyibudilast.ProcNatlAcadSciUSA.2010Jun22;107(25):11313-8.PMID:20534506.
LedeboerA,HutchinsonMR,WatkinsLR,etal.Ibudilast(AV-411).Anewclasstherapeuticcandidateforneuropathicpainandopioidwithdrawalsyndromes.ExpertOpinInvestigDrugs.2007Jul;16(7):935-50.PMID:17594181.
KishiY,OhtaS,KasuyaN,etal.Ibudilastmodulatesplatelet-endotheliuminteractionmainlythroughcyclicGMP-dependentmechanism.JCardiovascPharmacol.2000Jul;36(1):65-70.PMID:10892662.
OhashiM,KanaiR,NishinoK,etal.AntagoNISTiceffectofKC-404,anewanti-asthmaticagent,onleukotrieneD4-inducedcontractileresponsesinisolatedguineapigsmoothmuscles.Prostaglandins.1986Dec;32(6):875-88.PMID:3562868.
OhashiM,OhkuboH,KitoJ,etal.Anewvasodilator3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine(KC-404)hasadualmechanismofactiononplateletaggregation.ArchIntPharmacodynTher.1986Oct;283(2):321-34.PMID:3024600.